PRESS RELEASE published on 06/08/2026 at 08:00, 21 days 18 hours ago VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained PSR in the amount of €10.2M secured by commitments amounting to 76.6% Valbiotis announces the launch of a €10.2M capital increase with 76.6% secured commitments to fuel commercial expansion. The offering includes subscription price at €0.86/share, a discount, and expansion plans in Asia and the Middle East Capital Increase Valbiotis Discount Commercial Expansion PSR
BRIEF published on 06/08/2026 at 07:50, 21 days 18 hours ago Accord de distribution exclusif de Valbiotis au Qatar Valbiotis Moyen-Orient Accord Exclusif Cardiométabolique Distribution Qatar
BRIEF published on 06/08/2026 at 07:50, 21 days 18 hours ago Valbiotis Expands in the Middle East with Qatar Distribution Deal Distribution Agreement Valbiotis Qatar Cardiometabolic Middle East Expansion
BRIEF published on 06/08/2026 at 07:50, 21 days 18 hours ago Valbiotis se développe au Moyen-Orient grâce à un accord de distribution au Qatar Accord De Distribution Valbiotis Qatar Cardiométabolique Expansion Au Moyen-Orient
BRIEF published on 06/08/2026 at 07:50, 21 days 18 hours ago Exclusive distribution agreement for Valbiotis in Qatar Middle East Valbiotis Exclusive Agreement Cardiometabolic Qatar Distribution
PRESS RELEASE published on 06/08/2026 at 07:45, 21 days 18 hours ago VALBIOTIS SA: Valbiotis annonce la signature d’un accord de distribution exclusif au Qatar, une nouvelle étape dans le déploiement de la marque au Moyen-Orient Valbiotis annonce la signature d’un accord de distribution exclusif au Qatar avec Al Danah Medical, renforçant sa présence au Moyen-Orient. Les produits seront commercialisés en pharmacie avec une stratégie basée sur des données scientifiques solides Accord De Distribution Valbiotis Qatar Santé Cardiométabolique Al Danah Medical
PRESS RELEASE published on 06/08/2026 at 07:45, 21 days 18 hours ago VALBIOTIS SA: Valbiotis announces the signing of an exclusive distribution agreement in Qatar, a new milestone in the brand’s expansion in the Middle East Valbiotis signs exclusive distribution agreement with Al Danah Medical Company in Qatar, expanding presence in the Middle East. Launch of 4 products in 2027 Middle East Valbiotis Qatar Exclusive Distribution Agreement Al Danah Medical Company
PRESS RELEASE published on 06/08/2026 at 07:45, 21 days 18 hours ago VALBIOTIS SA: Valbiotis announces the signing of an exclusive distribution agreement in Qatar, a new milestone in the brand’s expansion in the Middle East Valbiotis signs exclusive distribution agreement in Qatar with Al Danah Medical Company, marking a milestone in brand's Middle East expansion. Agreement includes launch of 4 products. First revenues expected in 2027 Valbiotis Qatar Exclusive Distribution Agreement Middle East Expansion Al Danah Medical Company
PRESS RELEASE published on 06/08/2026 at 07:45, 21 days 18 hours ago VALBIOTIS SA: Valbiotis annonce la signature d’un accord de distribution exclusif au Qatar, une nouvelle étape dans le déploiement de la marque au Moyen-Orient Valbiotis SA annonce la signature d'un accord de distribution exclusif au Qatar avec Al Danah Medical Company, renforçant sa présence au Moyen-Orient Accord De Distribution Moyen-Orient Valbiotis SA Qatar Al Danah Medical Company
BRIEF published on 06/02/2026 at 10:05, 27 days 16 hours ago Valbiotis SA : Données mensuelles sur les droits de vote et le capital social Droits De Vote Franchissement De Seuil Actions Euronext Growth Valbiotis
Published on 06/30/2026 at 00:05, 2 hours 19 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 2 hours 38 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 4 hours 23 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 11 hours 24 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 22:47, 3 hours 37 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 4 hours 19 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 4 hours 19 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 5 hours 54 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 6 hours 24 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 7 hours 54 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 7 hours 54 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 8 hours 39 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 8 hours 39 minutes ago Déclaration hebdomadaire de rachat d'actions